Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

U.S. stocks are drifting near a record as Wall Street’s recent rally loses some momentum. The S&P 500 slipped 0.1% in early ...

Wall Street was mixed in premarket trading on Thursday as major U.S. airlines stumbled and health insurance companies soared.

Elevance Health (ELV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Scott Fidel from ...

Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...

For the year, the company reported profit of $5.98 billion, or $25.68 per share. Revenue was reported as $175.2 billion. Elevance Health expects full-year earnings in the range of $34.15 to $34.85 per ...

Health-care companies rose sharply amid strong earnings.

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Elevance Health (ELV), delve into some of its key metrics to gain a deeper insight into the company's potential performance for ...

Premium revenue is expected to rise in the low double-digit percentage range, while product revenue rises in the low single-digit range and service fees come in flat year-over-year. Overall, operating ...

Wall Street analysts forecast that Elevance Health (ELV) will report quarterly earnings of $3.82 per share in its upcoming release, pointing to a year-over-year decline of 32%. It is anticipated ...